10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 255 filers reported holding 10X GENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $716,678 | -26.1% | 17,374 | +0.0% | 0.02% | -22.6% |
| Q2 2023 | $969,941 | +0.0% | 17,370 | -0.1% | 0.03% | -6.1% |
| Q1 2023 | $969,574 | +30.5% | 17,379 | -14.8% | 0.03% | +3.1% |
| Q4 2022 | $742,975 | +29.0% | 20,389 | +0.8% | 0.03% | +18.5% |
| Q3 2022 | $576,000 | -36.9% | 20,235 | +0.3% | 0.03% | -35.7% |
| Q2 2022 | $913,000 | -39.6% | 20,166 | -0.3% | 0.04% | -30.0% |
| Q1 2022 | $1,512,000 | +36.7% | 20,234 | +172.5% | 0.06% | +46.3% |
| Q4 2021 | $1,106,000 | +110500.0% | 7,424 | +74140.0% | 0.04% | – |
| Q3 2021 | $1,000 | -50.0% | 10 | -9.1% | 0.00% | – |
| Q2 2021 | $2,000 | -99.7% | 11 | -99.7% | 0.00% | -100.0% |
| Q1 2021 | $630,000 | +20900.0% | 3,480 | +19233.3% | 0.03% | – |
| Q4 2020 | $3,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |